Novel systemic therapies in atopic dermatitis: what do we need to fulfil the promise of a treatment revolution? [version 1; referees: 3 approved]
Patients with atopic dermatitis (AD) who do not adequately respond to topical therapy and phototherapy often need systemic immunomodulatory treatment to control their symptoms. Conventional systemic agents, such as ciclosporin, azathioprine, and methotrexate, have been used for decades, but there ar...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2019-01-01
|
| Series: | F1000Research |
| Online Access: | https://f1000research.com/articles/8-132/v1 |